We need to pay attention: In the UK, a woman with a rare cancer has been refused coverage for chemo that would extend her life. From the story:
A dying mother last night became the human face of an election battle over the NHS. Nikki Phelps, 37, who has a rare glandular cancer, has been refused the only drug that could prolong her life. Despite pleas from her consultant, her local NHS trust says it will not meet the £100-a-day cost.
Labour ministers promised more than a year ago to give sufferers of rare cancers easier access to life-extending drugs. But the rationing body NICE has since refused to approve ten such drugs. Experts say the rulings cut short up to 20,000 lives.
Last night Mrs Phelps pleaded with the NHS to fund the drug Sutent, which she says will let her see her twins grow up. She said: ‘I can’t understand what the NHS is doing - where is the logic in investing in my treatment and then pulling the plug on me like this? ‘My consultant is an expert in the field, and he knows what’s best for me. Yet someone else is making a decision about what drugs I can and cannot take.’
It’s still not too late for us: Obamacare—Repeal. Reform. Replace.
We launched the First Things 2023 Year-End Campaign to keep articles like the one you just read free of charge to everyone.
Measured in dollars and cents, this doesn't make sense. But consider who is able to read First Things: pastors and priests, college students and professors, young professionals and families. Last year, we had more than three million unique readers on firstthings.com.
Informing and inspiring these people is why First Things doesn't only think in terms of dollars and cents. And it's why we urgently need your year-end support.
Will you give today?